Crescent Capital BDC (NASDAQ:CCAP) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) issued its quarterly earnings results on Monday. The company reported $0.59 earnings per share for the quarter, topping analysts’ consensus estimates of $0.58 by $0.01, Yahoo Finance reports. The company had revenue of $48.95 million during the quarter, compared to the consensus estimate of $48.05 million. Crescent Capital BDC had a net margin of 53.32% and a return on equity of 11.99%. During the same quarter in the prior year, the firm posted $0.56 EPS.

Crescent Capital BDC Price Performance

Shares of CCAP traded up $0.05 during trading hours on Wednesday, reaching $17.82. The stock had a trading volume of 79,518 shares, compared to its average volume of 141,705. The company has a debt-to-equity ratio of 1.11, a quick ratio of 1.36 and a current ratio of 1.36. Crescent Capital BDC has a 12 month low of $15.03 and a 12 month high of $19.63. The stock has a market capitalization of $660.44 million, a PE ratio of 6.32 and a beta of 0.81. The company’s 50-day moving average is $18.75 and its two-hundred day moving average is $17.72.

Crescent Capital BDC Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, September 16th. Shareholders of record on Saturday, August 31st will be paid a dividend of $0.09 per share. The ex-dividend date of this dividend is Friday, August 30th. This represents a $0.36 dividend on an annualized basis and a dividend yield of 2.02%. Crescent Capital BDC’s payout ratio is presently 59.79%.

Analyst Ratings Changes

Several research analysts have commented on the stock. Raymond James boosted their price objective on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the company an “outperform” rating in a research report on Friday, May 10th. Wells Fargo & Company dropped their price objective on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research report on Wednesday. Finally, Keefe, Bruyette & Woods lifted their target price on Crescent Capital BDC from $18.50 to $19.00 and gave the company an “outperform” rating in a research report on Thursday, May 23rd.

Read Our Latest Stock Analysis on Crescent Capital BDC

About Crescent Capital BDC

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Further Reading

Earnings History for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.